Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Leukemia, Myelogenous, Chronic, BCR-ABL Positive 32Leukemia 17Leukemia, Myeloid, Chronic-Phase 16Leukemia, Myeloid, Acute 14Breast Neoplasms 12Recurrence 11Leukemia, Lymphocytic, Chronic, B-Cell 10Prostatic Neoplasms 9Neoplasm Metastasis 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 7Blast Crisis 7Pancreatic Neoplasms 6Burkitt Lymphoma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 5Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Glioma 5Glioblastoma 5Philadelphia Chromosome 4Myelodysplastic Syndromes 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma 4Leukemia, Myeloid, Accelerated Phase 4Gliosarcoma 4Gastrointestinal Stromal Tumors 4Colorectal Neoplasms 4Waldenstrom Macroglobulinemia 3

Interventions

Dexamethasone 10Cyclophosphamide 9Cytarabine 7venetoclax 6Vincristine 6Methotrexate 5blinatumomab 4Prednisone 4Inotuzumab Ozogamicin 4Doxorubicin 4Rituximab 3prednylidene 2pegaspargase 2merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2deltacortene 2Mercaptopurine 2Etoposide 2Decitabine 2Calcium Dobesilate 2trametinib 1ruxolitinib 1olverembatinib 1ofatumumab 1nilotinib 1navitoclax 1fludarabine 1capivasertib 1azathiopurine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Dasatinib × Clear all
NCT05751044 2025-09-16

HEM-iSMART B

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Recruiting
26 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡